世俱杯2025赛程_中国足彩网首页官网_埃弗顿vs托特纳姆热刺_中国女排现状 - 奥运女足历届冠军一览表

  • 13585831301
  • 021-59541103 021-60443211
  • 3004967995

CUDC-907

  • 產品貨號:CS-01Y65568
  • 產品價格:電議
  • 產品產地:進口、國產
  • 包裝類型:10mM (in 1mL DMSO) 2mg 5mg 10mg 50mg 100mg
  • 采購熱度:282
  • 庫存:100
  • CAS號:1339928-25-4
  • 方法:
  • 含量:>98.00%
  • 品牌名稱:莼試
  • 分子式:C23H24N8O4S
  • 分子量:508.55

簡介內容:質量保證、價格優惠

在線訂購  免費訂購熱線:021-59541103 021-60443211

標簽:CUDC-907 

產品目錄

聯系我們

聯系人:高小姐

電話:021-59541103 021-60443211

手機:13585831301

Q Q: 3004967995

Email:3004967995@qq.com

詳細地址:上海嘉定區嘉羅公路1661

商品詳情購物流程代測服務付款方式常見問題

化學性質:                                                                                                             

規格

10mM (in 1mL DMSO) 2mg 5mg 10mg 50mg 100mg

CAS

1339928-25-4

別名

N/A

化學名

N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide

分子式

C23H24N8O4S

分子量

508.55

溶解度

25.45 mg/mL in DMSO

儲存條件

Store at -20°C

General tips

For obtaining a higher solubility , please warm the tube at 37 and shake it in the ultrasonic bath for a while.

Shipping Condition

Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request

 

產品描述:                                                                                                             

CUDC-907 is a dual-acting inhibitor of HDAC and PI3K with IC50 values of 1.7/5.0/1.8/2.8 nM (HDAC1/2/3/10) and 19/54/39 nM (PI3K).[1]

The phosphoinositide 3-kinases (PI3Ks) contain three classes of PI3K each with its own distinct lipid products and specific substrate. They are a family of lipid kinases that regulates a wide range of pathway by propagating intracellular signaling cascades. PI3K phosphorylates the 3’-OH group of phosphatidylinositols. This activated AKT, the protein Ser/Thr-kinase, by recruiting them to the cell membrane. The PI3K/AKT signaling pathway is critical in cancer, because it promotes cell growth and survival. The studies have proved that PI3K pathway plays an important role in cancer progression and treatment for lung cancers, breast cancer.[2, 3] Histone deacetylases (HDACs) and histone acetyltransferases (HATs) mediates the balance between histone deacetylation and acetylation. HDACs also regulate the acetylation status of signaling molecules, chaperones, and transcription factors that are non-histone proteins.[4]

CUDC-907 is a potent inhibitor of class I PI3K kinases and HDAC classes I and II enzymes. CUDC-907 resulted in increase of acetylated histones and non-histone proteins such as tubulin and p53. CUDC-907 also induced p21 protein in H460 cell lines. CUDC-907 dose-dependently decreases phosphorylation of AKT and its downstream targets, p70S6 and 4EBP-1 by inhibiting the PI3K pathway,, in H460 cells. CUDC-907 were able to inhibit the activation of MEK in cancer cell lines including NSCLC H460 cells, breast cancer BT-474 cells and NSCLC H1975 cells. CUDC-907 suppresses the RAF- MEK-MAPK signaling pathway through HDAC inhibition. CUDC-907 can also cause the decrease of both p-SRC) and p-SRC in RPMI-8226 multiple myeloma cells. CUDC-907 induced cell-cycle arrest at G2–M phase at the dose of 1 μM for 24h.[1]

CUDC-907 inhibited growth of the tumor in Daudi cancer cell xenografts dose-dependently. In a xenograft tumor model of DLBCL (SU-DHL4 diffuselarge B-cell lymphoma) CUDC-907 induced tumor regression after oral administration (100 mg/kg) or intravenous (50 mg/kg). CUDC-907 also caused tumor stasis in NSCLC cell xenografts [1].

References:

[1].  Qian C, Lai CJ, Bao R, Wang DG, Wang J, Xu GX, Atoyan R, Qu H, Yin L, Samson M et al: Cancer network disruption by a single molecule inhibitor targeting both histone deacetylase activity and phosphatidylinositol 3-kinase signaling. Clin Cancer Res 2012, 18(15):4104-4113.

[2].  Wong KK, Engelman JA, Cantley LC: Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 2010, 20(1):87-90.

[3].  Engelman JA: Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009, 9(8):550-562.

[4].  Kim HJ, Bae SC: Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 2011, 3(2):166-179.

 

特別提醒:                                                                                                              

1. 本產品僅供科研使用。請勿用于醫藥、臨床診斷或治療,食品及化妝品等用途。請勿存放于普通住宅區。

2. 為了您的安全和健康,請穿好實驗服并佩戴一次性手套和口罩操作。

原創作者:上海莼試生物技術有限公司

在線咨詢

留言注意事項:

1.遵守中華人民共和國有關法律、法規,尊重網上道德,承擔一切因您的行為而直接或間接引起的法律責任。

2.請您真實的反映產品的情況,不要捏造、誣蔑、造謠。如對產品有任何疑問,也可以留言咨詢。

3.未經本站同意,任何人不得利用本留言簿發布個人或團體的具有廣告性質的信息或類似言論。

    您感興趣的產品*
    您的單位*
    聯系人*
    聯系電話*
    詳細地址*
    常用郵箱*
    請輸入您對我們的意見或建議*
    驗證碼*

同類產品

訂購流程

訂貨流程

產品訂購說明:

  

1、報價含普票、運費。

2、常用試劑備貨充足,除對溫度要求極其嚴格的產品當天可發貨。

  

3、進口原裝產品要3-6周的貨期,詳細情況請咨詢客服。

  

4、訂貨時間為工作日每周一至周五16:00之前。

  

5、如需代為檢測,標本對環境溫度高,可聯系客服安排專人取樣(限省內客戶)。

  

6、代測免收代測費,一周出結果。

7、產品因運輸途中包裝破損請拒絕簽收,做退回。我們將在24小時之內為您補發 損壞產品。

8、如因單位財務制度原因,可申請先發貨,報賬后付款(此條款僅限醫院、學校信譽良好客戶)。

付款方式

普票匯款信息

  

賬 戶 名:上海生物

開 戶 行:中國銀行山東省分行營業部

  

賬 號:2169 2341 6278

 為方便廣大客戶辦理貨款我公司提供多個銀行的賬戶,學校、醫院客戶購買產品如因單位財務制度原因可先發貨待報賬后匯款,請及時告知銷售人員已做具體操作。